Viola Ventures (formerly Carmel Ventures)

Viola Ventures (formerly Carmel Ventures)

Viola Ventures is a venture capital firm that invests in Israeli-related early-stage companies.

Company Overview

Viola Ventures (Hebrew: ויולה ונצ'רס ), (formerly Carmel Ventures (Hebrew: כרמל ונצ'רס )), established in 2000, is an Israeli venture capital fund with over $1.3 billion under management. Viola Ventures is focused on early-stage companies in the fields of enterprise infrastructure and applications, frontier and deep technologies (automotive, IOT, AR/VR, drones), software, software as a service, financial technology, Internet, media, communications, semiconductors, and consumer electronics. Viola Ventures is a member of the Viola Group, a private equity investment group with over $2.8B under management, focused on technology-based investment opportunities in Israel. Shlomo Dovrat was a founder.

History

Viola Ventures (formerly Carmel Ventures) is a venture capital firm that invests in Israeli-related early stage companies with significant ideas that can lead to transformational companies. Founded in 2000 by Avi Zeevi and Shlomo Dovrat, Viola Ventures manages over $1B across five funds and is the only Israel-based VC fund with six investing partners solely dedicated to early-stage tech investments. This allows for unique depth and diversification that spans across a wide range of backgrounds and verticals. With a portfolio of over 90 companies, Viola Ventures has backed a substantial share of Israel's exits to date, including Actimize, RedBend, DesignArt, CopperGate, Exelate, and ECI.

With over $1B million under management, several successful exits, and a growing portfolio of promising companies, Viola is among Israel's top-tier venture capital funds. Viola provides significant capital and active support through the growth cycle of its portfolio companies and is recognized as a true company building fund in Israel. The firm's Fund IV has funded early-stage tech companies, with the help of Asian investors like Baidu.

Focus Industries:

Preferred Financing Stage:

  • Seed
  • 1st Round
  • 2nd Round
  • 3rd Round
  • 4th Round and later
  • Pre-IPO (initial public offering)
  • Mezzanine Buyout/acquisition

Preferred Company Type:

  • Private Company(backed by venture capital firms)
  • Private Company(not backed by venture capital firms)
  • Public Company.

Investments

Viola Ventures has made 189 investments. One of their investments was on February 19, 2019, when they invested $60M in Redis Labs. The firm has raised a total of $1B across 5 funds, one of them being Carmel Ventures V. This fund was announced on Nov 1, 2017, and raised a total of $200M.

Timeline

February 19, 2019

Redis Labs.

$60M

November 1, 2017

Carmel Ventures V.

$200M.

2000

Founded in 2000 by Avi Zeevi and Shlomo Dovrat, Viola Ventures manages over $1B across five funds, and is the only Israel-based VC fund with six investing partners solely dedicated to early-stage tech investments.

Funded Companies

Company
Description
Website
Industry
Location

Founded in 2012, playbuzz is an online publishing platform for publishers, brand agencies and individual content creators to create content in interactive formats such as polls, quizzes, lists, video snippets, slideshows, and countdowns.

Splacer is a company founded in 2014 by Adi Biran.

Redis Labs is the open source home and commercial provider of the Redis database.

Puls is a company founded by Eyal Ronen.

EverCompliant is an Israel-based artificial intelligence company.

Pliops is a San Jose, California-based company founded by Uri Beitler.

nsKnox is an Israel-based artificial intelligence company.

Vayavision is an Israel-based artificial intelligence company.

Adapteva is a Lexington, Massachusetts-based company.

17 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
May 14, 2020
WebWire
Today, Immunai launches out of stealth to map the entire immune system for better detection, diagnosis, and treatment of disease. Leveraging single-cell technologies and machine learning algorithms, Immunai has mapped out millions of immune cells and their functions, building the largest proprietary data set in the world for clinical immunological data. The company is also announcing $20M in seed funding, which will be used to further the development of its technology and business functi...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.